QuidelOrtho Corporation (QDEL) Q4 FY25 Earnings Call

Cost savings and lab growth improved profitability, but respiratory variability and cash conversion remain key swing factors.

Q4 FY25 results, source: company transcript and SEC filings
QuarterQ4 FY25
Call date2026-02-16
Length60 minutes
EPS$0.46
EPS consensus$0.43
Revenue$723.6M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q2 FY26

All QDEL earnings ยท Back to QDEL overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.